| Description | Gliclazide (SE1702), an oral antihyperglycemic agent, belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating beta-cells of the pancreas to release insulin. |
| Target activity | K+ channel:184 nM |
| Synonyms | 格列齐特, S1702, SE1702 |
| molecular weight | 323.41 |
| Molecular formula | C15H21N3O3S |
| CAS | 21187-98-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 45 mg/mL (139.14 mM), Sonication is recommended. |
| References | 1. Mamputu JC, Renier G. J Diabetes Complications. 2002 Jul-Aug;16(4):284-93. |